Reports

Industry Research Reports

description

Part 1

description

Part 2

description

Part 3

description

Part 4

description

Part 5

Home > Reports > Medical Devices & Consumables > Global Anaphylaxis Autoinjectors Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Anaphylaxis Autoinjectors Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Anaphylaxis Autoinjectors Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Devices & Consumables

Published: 2025-02-14

Pages: 79 Pages

Report ld: 3892213

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

Description

The global Anaphylaxis Autoinjectors market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. 
The North America Anaphylaxis Autoinjectors market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Anaphylaxis Autoinjectors include Ypsomed Holding, Novartis, BD, Medmix Healthcare, Eli Lilly and Company, Sanofi, Mylan, Amgen, SHL Medical, Recipharm, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Anaphylaxis Autoinjectors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anaphylaxis Autoinjectors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

Market Segmentation

  • Report Metric

  • Details

  • Report Title

  • Global Anaphylaxis Autoinjectors Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  • Market Size Available for Years

  • 2025-2031

  • Global Anaphylaxis Autoinjectors Companies Covered

  • Ypsomed Holding

    Novartis

    BD

    Medmix Healthcare

    Eli Lilly and Company

    Sanofi

    Mylan

    Amgen

    SHL Medical

    Recipharm

  • Global Anaphylaxis Autoinjectors Market, by Region

  • North America (U.S., Canada, Mexico)

    Europe (Germany, France, UK, Italy, etc.)

    Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

    South America (Brazil, etc.)

    Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

  • Global Anaphylaxis Autoinjectors Market, Segment by Type

  • Handheld Type

    Wearable Type

  • Global Anaphylaxis Autoinjectors Market, Segment by Application

  • Homecare Settings

    Hospitals & Clinics

  • Forecast Units

  • Million USD

  • Report Coverage

  • Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Anaphylaxis Autoinjectors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Anaphylaxis Autoinjectors manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anaphylaxis Autoinjectors revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Table of Contents

1 Market Overview
    1.1 Anaphylaxis Autoinjectors Product Scope
    1.2 Anaphylaxis Autoinjectors by Type
        1.2.1 Global Anaphylaxis Autoinjectors Sales by Type (2020 & 2024 & 2031)
        1.2.2 Handheld Type
        1.2.3 Wearable Type
    1.3 Anaphylaxis Autoinjectors by Application
        1.3.1 Global Anaphylaxis Autoinjectors Sales Comparison by Application (2020 & 2024 & 2031)
        1.3.2 Homecare Settings
        1.3.3 Hospitals & Clinics
    1.4 Global Anaphylaxis Autoinjectors Market Estimates and Forecasts (2020-2031)
        1.4.1 Global Anaphylaxis Autoinjectors Market Size in Value Growth Rate (2020-2031)
        1.4.2 Global Anaphylaxis Autoinjectors Market Size in Volume Growth Rate (2020-2031)
        1.4.3 Global Anaphylaxis Autoinjectors Price Trends (2020-2031)
    1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
    2.1 Global Anaphylaxis Autoinjectors Market Size by Region: 2020 VS 2024 VS 2031
    2.2 Global Anaphylaxis Autoinjectors Retrospective Market Scenario by Region (2020-2025)
        2.2.1 Global Anaphylaxis Autoinjectors Sales Market Share by Region (2020-2025)
        2.2.2 Global Anaphylaxis Autoinjectors Revenue Market Share by Region (2020-2025)
    2.3 Global Anaphylaxis Autoinjectors Market Estimates and Forecasts by Region (2026-2031)
        2.3.1 Global Anaphylaxis Autoinjectors Sales Estimates and Forecasts by Region (2026-2031)
        2.3.2 Global Anaphylaxis Autoinjectors Revenue Forecast by Region (2026-2031)
    2.4 Major Region and Emerging Market Analysis
        2.4.1 North America Anaphylaxis Autoinjectors Market Size and Prospective (2020-2031)
        2.4.2 Europe Anaphylaxis Autoinjectors Market Size and Prospective (2020-2031)
        2.4.3 China Anaphylaxis Autoinjectors Market Size and Prospective (2020-2031)
        2.4.4 Japan Anaphylaxis Autoinjectors Market Size and Prospective (2020-2031)
3 Global Market Size by Type
    3.1 Global Anaphylaxis Autoinjectors Historic Market Review by Type (2020-2025)
        3.1.1 Global Anaphylaxis Autoinjectors Sales by Type (2020-2025)
        3.1.2 Global Anaphylaxis Autoinjectors Revenue by Type (2020-2025)
        3.1.3 Global Anaphylaxis Autoinjectors Price by Type (2020-2025)
    3.2 Global Anaphylaxis Autoinjectors Market Estimates and Forecasts by Type (2026-2031)
        3.2.1 Global Anaphylaxis Autoinjectors Sales Forecast by Type (2026-2031)
        3.2.2 Global Anaphylaxis Autoinjectors Revenue Forecast by Type (2026-2031)
        3.2.3 Global Anaphylaxis Autoinjectors Price Forecast by Type (2026-2031)
    3.3 Different Types Anaphylaxis Autoinjectors Representative Players
4 Global Market Size by Application
    4.1 Global Anaphylaxis Autoinjectors Historic Market Review by Application (2020-2025)
        4.1.1 Global Anaphylaxis Autoinjectors Sales by Application (2020-2025)
        4.1.2 Global Anaphylaxis Autoinjectors Revenue by Application (2020-2025)
        4.1.3 Global Anaphylaxis Autoinjectors Price by Application (2020-2025)
    4.2 Global Anaphylaxis Autoinjectors Market Estimates and Forecasts by Application (2026-2031)
        4.2.1 Global Anaphylaxis Autoinjectors Sales Forecast by Application (2026-2031)
        4.2.2 Global Anaphylaxis Autoinjectors Revenue Forecast by Application (2026-2031)
        4.2.3 Global Anaphylaxis Autoinjectors Price Forecast by Application (2026-2031)
    4.3 New Sources of Growth in Anaphylaxis Autoinjectors Application
5 Competition Landscape by Players
    5.1 Global Anaphylaxis Autoinjectors Sales by Players (2020-2025)
    5.2 Global Top Anaphylaxis Autoinjectors Players by Revenue (2020-2025)
    5.3 Global Anaphylaxis Autoinjectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anaphylaxis Autoinjectors as of 2024)
    5.4 Global Anaphylaxis Autoinjectors Average Price by Company (2020-2025)
    5.5 Global Key Manufacturers of Anaphylaxis Autoinjectors, Manufacturing Sites & Headquarters
    5.6 Global Key Manufacturers of Anaphylaxis Autoinjectors, Product Type & Application
    5.7 Global Key Manufacturers of Anaphylaxis Autoinjectors, Date of Enter into This Industry
    5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
    6.1 North America Market: Players, Segments, Downstream and Major Customers
        6.1.1 North America Anaphylaxis Autoinjectors Sales by Company
            6.1.1.1 North America Anaphylaxis Autoinjectors Sales by Company (2020-2025)
            6.1.1.2 North America Anaphylaxis Autoinjectors Revenue by Company (2020-2025)
        6.1.2 North America Anaphylaxis Autoinjectors Sales Breakdown by Type (2020-2025)
        6.1.3 North America Anaphylaxis Autoinjectors Sales Breakdown by Application (2020-2025)
        6.1.4 North America Anaphylaxis Autoinjectors Major Customer
        6.1.5 North America Market Trend and Opportunities
    6.2 Europe Market: Players, Segments, Downstream and Major Customers
        6.2.1 Europe Anaphylaxis Autoinjectors Sales by Company
            6.2.1.1 Europe Anaphylaxis Autoinjectors Sales by Company (2020-2025)
            6.2.1.2 Europe Anaphylaxis Autoinjectors Revenue by Company (2020-2025)
        6.2.2 Europe Anaphylaxis Autoinjectors Sales Breakdown by Type (2020-2025)
        6.2.3 Europe Anaphylaxis Autoinjectors Sales Breakdown by Application (2020-2025)
        6.2.4 Europe Anaphylaxis Autoinjectors Major Customer
        6.2.5 Europe Market Trend and Opportunities
    6.3 China Market: Players, Segments, Downstream and Major Customers
        6.3.1 China Anaphylaxis Autoinjectors Sales by Company
            6.3.1.1 China Anaphylaxis Autoinjectors Sales by Company (2020-2025)
            6.3.1.2 China Anaphylaxis Autoinjectors Revenue by Company (2020-2025)
        6.3.2 China Anaphylaxis Autoinjectors Sales Breakdown by Type (2020-2025)
        6.3.3 China Anaphylaxis Autoinjectors Sales Breakdown by Application (2020-2025)
        6.3.4 China Anaphylaxis Autoinjectors Major Customer
        6.3.5 China Market Trend and Opportunities
    6.4 Japan Market: Players, Segments, Downstream and Major Customers
        6.4.1 Japan Anaphylaxis Autoinjectors Sales by Company
            6.4.1.1 Japan Anaphylaxis Autoinjectors Sales by Company (2020-2025)
            6.4.1.2 Japan Anaphylaxis Autoinjectors Revenue by Company (2020-2025)
        6.4.2 Japan Anaphylaxis Autoinjectors Sales Breakdown by Type (2020-2025)
        6.4.3 Japan Anaphylaxis Autoinjectors Sales Breakdown by Application (2020-2025)
        6.4.4 Japan Anaphylaxis Autoinjectors Major Customer
        6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
    7.1 Ypsomed Holding
        7.1.1 Ypsomed Holding Company Information
        7.1.2 Ypsomed Holding Business Overview
        7.1.3 Ypsomed Holding Anaphylaxis Autoinjectors Sales, Revenue and Gross Margin (2020-2025)
        7.1.4 Ypsomed Holding Anaphylaxis Autoinjectors Products Offered
        7.1.5 Ypsomed Holding Recent Development
    7.2 Novartis
        7.2.1 Novartis Company Information
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Anaphylaxis Autoinjectors Sales, Revenue and Gross Margin (2020-2025)
        7.2.4 Novartis Anaphylaxis Autoinjectors Products Offered
        7.2.5 Novartis Recent Development
    7.3 BD
        7.3.1 BD Company Information
        7.3.2 BD Business Overview
        7.3.3 BD Anaphylaxis Autoinjectors Sales, Revenue and Gross Margin (2020-2025)
        7.3.4 BD Anaphylaxis Autoinjectors Products Offered
        7.3.5 BD Recent Development
    7.4 Medmix Healthcare
        7.4.1 Medmix Healthcare Company Information
        7.4.2 Medmix Healthcare Business Overview
        7.4.3 Medmix Healthcare Anaphylaxis Autoinjectors Sales, Revenue and Gross Margin (2020-2025)
        7.4.4 Medmix Healthcare Anaphylaxis Autoinjectors Products Offered
        7.4.5 Medmix Healthcare Recent Development
    7.5 Eli Lilly and Company
        7.5.1 Eli Lilly and Company Company Information
        7.5.2 Eli Lilly and Company Business Overview
        7.5.3 Eli Lilly and Company Anaphylaxis Autoinjectors Sales, Revenue and Gross Margin (2020-2025)
        7.5.4 Eli Lilly and Company Anaphylaxis Autoinjectors Products Offered
        7.5.5 Eli Lilly and Company Recent Development
    7.6 Sanofi
        7.6.1 Sanofi Company Information
        7.6.2 Sanofi Business Overview
        7.6.3 Sanofi Anaphylaxis Autoinjectors Sales, Revenue and Gross Margin (2020-2025)
        7.6.4 Sanofi Anaphylaxis Autoinjectors Products Offered
        7.6.5 Sanofi Recent Development
    7.7 Mylan
        7.7.1 Mylan Company Information
        7.7.2 Mylan Business Overview
        7.7.3 Mylan Anaphylaxis Autoinjectors Sales, Revenue and Gross Margin (2020-2025)
        7.7.4 Mylan Anaphylaxis Autoinjectors Products Offered
        7.7.5 Mylan Recent Development
    7.8 Amgen
        7.8.1 Amgen Company Information
        7.8.2 Amgen Business Overview
        7.8.3 Amgen Anaphylaxis Autoinjectors Sales, Revenue and Gross Margin (2020-2025)
        7.8.4 Amgen Anaphylaxis Autoinjectors Products Offered
        7.8.5 Amgen Recent Development
    7.9 SHL Medical
        7.9.1 SHL Medical Company Information
        7.9.2 SHL Medical Business Overview
        7.9.3 SHL Medical Anaphylaxis Autoinjectors Sales, Revenue and Gross Margin (2020-2025)
        7.9.4 SHL Medical Anaphylaxis Autoinjectors Products Offered
        7.9.5 SHL Medical Recent Development
    7.10 Recipharm
        7.10.1 Recipharm Company Information
        7.10.2 Recipharm Business Overview
        7.10.3 Recipharm Anaphylaxis Autoinjectors Sales, Revenue and Gross Margin (2020-2025)
        7.10.4 Recipharm Anaphylaxis Autoinjectors Products Offered
        7.10.5 Recipharm Recent Development
8 Anaphylaxis Autoinjectors Manufacturing Cost Analysis
    8.1 Anaphylaxis Autoinjectors Key Raw Materials Analysis
        8.1.1 Key Raw Materials
        8.1.2 Key Suppliers of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
    8.3 Manufacturing Process Analysis of Anaphylaxis Autoinjectors
    8.4 Anaphylaxis Autoinjectors Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
    9.1 Marketing Channel
    9.2 Anaphylaxis Autoinjectors Distributors List
    9.3 Anaphylaxis Autoinjectors Customers
10 Anaphylaxis Autoinjectors Market Dynamics
    10.1 Anaphylaxis Autoinjectors Industry Trends
    10.2 Anaphylaxis Autoinjectors Market Drivers
    10.3 Anaphylaxis Autoinjectors Market Challenges
    10.4 Anaphylaxis Autoinjectors Market Restraints
11 Research Findings and Conclusion
12 Appendix
    12.1 Research Methodology
        12.1.1 Methodology/Research Approach
            12.1.1.1 Research Programs/Design
            12.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        12.1.2 Data Source
            12.1.2.1 Secondary Sources
            12.1.2.2 Primary Sources
    12.2 Author Details
    12.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Anaphylaxis Autoinjectors Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
 Table 2. Global Anaphylaxis Autoinjectors Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
 Table 3. Global Market Anaphylaxis Autoinjectors Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Table 4. Global Anaphylaxis Autoinjectors Sales (K Units) by Region (2020-2025)
 Table 5. Global Anaphylaxis Autoinjectors Sales Market Share by Region (2020-2025)
 Table 6. Global Anaphylaxis Autoinjectors Revenue (US$ Million) Market Share by Region (2020-2025)
 Table 7. Global Anaphylaxis Autoinjectors Revenue Share by Region (2020-2025)
 Table 8. Global Anaphylaxis Autoinjectors Sales (K Units) Forecast by Region (2026-2031)
 Table 9. Global Anaphylaxis Autoinjectors Sales Market Share Forecast by Region (2026-2031)
 Table 10. Global Anaphylaxis Autoinjectors Revenue (US$ Million) Forecast by Region (2026-2031)
 Table 11. Global Anaphylaxis Autoinjectors Revenue Share Forecast by Region (2026-2031)
 Table 12. Global Anaphylaxis Autoinjectors Sales by Type (K Units) & (2020-2025)
 Table 13. Global Anaphylaxis Autoinjectors Sales Share by Type (2020-2025)
 Table 14. Global Anaphylaxis Autoinjectors Revenue by Type (US$ Million) & (2020-2025)
 Table 15. Global Anaphylaxis Autoinjectors Price by Type (US$/Unit) & (2020-2025)
 Table 16. Global Anaphylaxis Autoinjectors Sales by Type (K Units) & (2026-2031)
 Table 17. Global Anaphylaxis Autoinjectors Revenue by Type (US$ Million) & (2026-2031)
 Table 18. Global Anaphylaxis Autoinjectors Price by Type (US$/Unit) & (2026-2031)
 Table 19. Representative Players of Each Type
 Table 20. Global Anaphylaxis Autoinjectors Sales by Application (K Units) & (2020-2025)
 Table 21. Global Anaphylaxis Autoinjectors Sales Share by Application (2020-2025)
 Table 22. Global Anaphylaxis Autoinjectors Revenue by Application (US$ Million) & (2020-2025)
 Table 23. Global Anaphylaxis Autoinjectors Price by Application (US$/Unit) & (2020-2025)
 Table 24. Global Anaphylaxis Autoinjectors Sales by Application (K Units) & (2026-2031)
 Table 25. Global Anaphylaxis Autoinjectors Revenue Market Share by Application (US$ Million) & (2026-2031)
 Table 26. Global Anaphylaxis Autoinjectors Price by Application (US$/Unit) & (2026-2031)
 Table 27. New Sources of Growth in Anaphylaxis Autoinjectors Application
 Table 28. Global Anaphylaxis Autoinjectors Sales by Company (K Units) & (2020-2025)
 Table 29. Global Anaphylaxis Autoinjectors Sales Share by Company (2020-2025)
 Table 30. Global Anaphylaxis Autoinjectors Revenue by Company (US$ Million) & (2020-2025)
 Table 31. Global Anaphylaxis Autoinjectors Revenue Share by Company (2020-2025)
 Table 32. Global Anaphylaxis Autoinjectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anaphylaxis Autoinjectors as of 2024)
 Table 33. Global Market Anaphylaxis Autoinjectors Average Price by Company (US$/Unit) & (2020-2025)
 Table 34. Global Key Manufacturers of Anaphylaxis Autoinjectors, Manufacturing Sites & Headquarters
 Table 35. Global Key Manufacturers of Anaphylaxis Autoinjectors, Product Type & Application
 Table 36. Global Key Manufacturers of Anaphylaxis Autoinjectors, Date of Enter into This Industry
 Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 38. North America Anaphylaxis Autoinjectors Sales by Company (2020-2025) & (K Units)
 Table 39. North America Anaphylaxis Autoinjectors Sales Market Share by Company (2020-2025)
 Table 40. North America Anaphylaxis Autoinjectors Revenue by Company (2020-2025) & (US$ Million)
 Table 41. North America Anaphylaxis Autoinjectors Revenue Market Share by Company (2020-2025)
 Table 42. North America Anaphylaxis Autoinjectors Sales by Type (2020-2025) & (K Units)
 Table 43. North America Anaphylaxis Autoinjectors Sales Market Share by Type (2020-2025)
 Table 44. North America Anaphylaxis Autoinjectors Sales by Application (2020-2025) & (K Units)
 Table 45. North America Anaphylaxis Autoinjectors Sales Market Share by Application (2020-2025)
 Table 46. Europe Anaphylaxis Autoinjectors Sales by Company (2020-2025) & (K Units)
 Table 47. Europe Anaphylaxis Autoinjectors Sales Market Share by Company (2020-2025)
 Table 48. Europe Anaphylaxis Autoinjectors Revenue by Company (2020-2025) & (US$ Million)
 Table 49. Europe Anaphylaxis Autoinjectors Revenue Market Share by Company (2020-2025)
 Table 50. Europe Anaphylaxis Autoinjectors Sales by Type (2020-2025) & (K Units)
 Table 51. Europe Anaphylaxis Autoinjectors Sales Market Share by Type (2020-2025)
 Table 52. Europe Anaphylaxis Autoinjectors Sales by Application (2020-2025) & (K Units)
 Table 53. Europe Anaphylaxis Autoinjectors Sales Market Share by Application (2020-2025)
 Table 54. China Anaphylaxis Autoinjectors Sales by Company (2020-2025) & (K Units)
 Table 55. China Anaphylaxis Autoinjectors Sales Market Share by Company (2020-2025)
 Table 56. China Anaphylaxis Autoinjectors Revenue by Company (2020-2025) & (US$ Million)
 Table 57. China Anaphylaxis Autoinjectors Revenue Market Share by Company (2020-2025)
 Table 58. China Anaphylaxis Autoinjectors Sales by Type (2020-2025) & (K Units)
 Table 59. China Anaphylaxis Autoinjectors Sales Market Share by Type (2020-2025)
 Table 60. China Anaphylaxis Autoinjectors Sales by Application (2020-2025) & (K Units)
 Table 61. China Anaphylaxis Autoinjectors Sales Market Share by Application (2020-2025)
 Table 62. Japan Anaphylaxis Autoinjectors Sales by Company (2020-2025) & (K Units)
 Table 63. Japan Anaphylaxis Autoinjectors Sales Market Share by Company (2020-2025)
 Table 64. Japan Anaphylaxis Autoinjectors Revenue by Company (2020-2025) & (US$ Million)
 Table 65. Japan Anaphylaxis Autoinjectors Revenue Market Share by Company (2020-2025)
 Table 66. Japan Anaphylaxis Autoinjectors Sales by Type (2020-2025) & (K Units)
 Table 67. Japan Anaphylaxis Autoinjectors Sales Market Share by Type (2020-2025)
 Table 68. Japan Anaphylaxis Autoinjectors Sales by Application (2020-2025) & (K Units)
 Table 69. Japan Anaphylaxis Autoinjectors Sales Market Share by Application (2020-2025)
 Table 70. Ypsomed Holding Company Information
 Table 71. Ypsomed Holding Description and Business Overview
 Table 72. Ypsomed Holding Anaphylaxis Autoinjectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Ypsomed Holding Anaphylaxis Autoinjectors Product
 Table 74. Ypsomed Holding Recent Development
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis Anaphylaxis Autoinjectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Novartis Anaphylaxis Autoinjectors Product
 Table 79. Novartis Recent Development
 Table 80. BD Company Information
 Table 81. BD Description and Business Overview
 Table 82. BD Anaphylaxis Autoinjectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BD Anaphylaxis Autoinjectors Product
 Table 84. BD Recent Development
 Table 85. Medmix Healthcare Company Information
 Table 86. Medmix Healthcare Description and Business Overview
 Table 87. Medmix Healthcare Anaphylaxis Autoinjectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Medmix Healthcare Anaphylaxis Autoinjectors Product
 Table 89. Medmix Healthcare Recent Development
 Table 90. Eli Lilly and Company Company Information
 Table 91. Eli Lilly and Company Description and Business Overview
 Table 92. Eli Lilly and Company Anaphylaxis Autoinjectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Eli Lilly and Company Anaphylaxis Autoinjectors Product
 Table 94. Eli Lilly and Company Recent Development
 Table 95. Sanofi Company Information
 Table 96. Sanofi Description and Business Overview
 Table 97. Sanofi Anaphylaxis Autoinjectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sanofi Anaphylaxis Autoinjectors Product
 Table 99. Sanofi Recent Development
 Table 100. Mylan Company Information
 Table 101. Mylan Description and Business Overview
 Table 102. Mylan Anaphylaxis Autoinjectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Mylan Anaphylaxis Autoinjectors Product
 Table 104. Mylan Recent Development
 Table 105. Amgen Company Information
 Table 106. Amgen Description and Business Overview
 Table 107. Amgen Anaphylaxis Autoinjectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Amgen Anaphylaxis Autoinjectors Product
 Table 109. Amgen Recent Development
 Table 110. SHL Medical Company Information
 Table 111. SHL Medical Description and Business Overview
 Table 112. SHL Medical Anaphylaxis Autoinjectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. SHL Medical Anaphylaxis Autoinjectors Product
 Table 114. SHL Medical Recent Development
 Table 115. Recipharm Company Information
 Table 116. Recipharm Description and Business Overview
 Table 117. Recipharm Anaphylaxis Autoinjectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Recipharm Anaphylaxis Autoinjectors Product
 Table 119. Recipharm Recent Development
 Table 120. Production Base and Market Concentration Rate of Raw Material
 Table 121. Key Suppliers of Raw Materials
 Table 122. Anaphylaxis Autoinjectors Distributors List
 Table 123. Anaphylaxis Autoinjectors Customers List
 Table 124. Anaphylaxis Autoinjectors Market Trends
 Table 125. Anaphylaxis Autoinjectors Market Drivers
 Table 126. Anaphylaxis Autoinjectors Market Challenges
 Table 127. Anaphylaxis Autoinjectors Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. Anaphylaxis Autoinjectors Product Picture
 Figure 2. Global Anaphylaxis Autoinjectors Sales (US$ Million) by Type (2020 & 2024 & 2031)
 Figure 3. Global Anaphylaxis Autoinjectors Sales Market Share by Type in 2024 & 2031
 Figure 4. Handheld Type Product Picture
 Figure 5. Wearable Type Product Picture
 Figure 6. Global Anaphylaxis Autoinjectors Sales (US$ Million) by Application (2020 & 2024 & 2031)
 Figure 7. Global Anaphylaxis Autoinjectors Sales Market Share by Application in 2024 & 2031
 Figure 8. Homecare Settings Examples
 Figure 9. Hospitals & Clinics Examples
 Figure 10. Global Anaphylaxis Autoinjectors Sales, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Anaphylaxis Autoinjectors Sales Growth Rate (2020-2031) & (US$ Million)
 Figure 12. Global Anaphylaxis Autoinjectors Sales (K Units) Growth Rate (2020-2031)
 Figure 13. Global Anaphylaxis Autoinjectors Price Trends Growth Rate (2020-2031) & (US$/Unit)
 Figure 14. Anaphylaxis Autoinjectors Report Years Considered
 Figure 15. Global Market Anaphylaxis Autoinjectors Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
 Figure 16. Global Anaphylaxis Autoinjectors Revenue Market Share by Region: 2020 VS 2024
 Figure 17. North America Anaphylaxis Autoinjectors Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 18. North America Anaphylaxis Autoinjectors Sales (K Units) Growth Rate (2020-2031)
 Figure 19. Europe Anaphylaxis Autoinjectors Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 20. Europe Anaphylaxis Autoinjectors Sales (K Units) Growth Rate (2020-2031)
 Figure 21. China Anaphylaxis Autoinjectors Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 22. China Anaphylaxis Autoinjectors Sales (K Units) Growth Rate (2020-2031)
 Figure 23. Japan Anaphylaxis Autoinjectors Revenue (US$ Million) Growth Rate (2020-2031)
 Figure 24. Japan Anaphylaxis Autoinjectors Sales (K Units) Growth Rate (2020-2031)
 Figure 25. Global Anaphylaxis Autoinjectors Revenue Share by Type (2020-2025)
 Figure 26. Global Anaphylaxis Autoinjectors Sales Share by Type (2026-2031)
 Figure 27. Global Anaphylaxis Autoinjectors Revenue Share by Type (2026-2031)
 Figure 28. Global Anaphylaxis Autoinjectors Revenue Share by Application (2020-2025)
 Figure 29. Global Anaphylaxis Autoinjectors Revenue Growth Rate by Application in 2020 & 2024
 Figure 30. Global Anaphylaxis Autoinjectors Sales Share by Application (2026-2031)
 Figure 31. Global Anaphylaxis Autoinjectors Revenue Share by Application (2026-2031)
 Figure 32. Global Anaphylaxis Autoinjectors Sales Share by Company (2024)
 Figure 33. Global Anaphylaxis Autoinjectors Revenue Share by Company (2024)
 Figure 34. Global 5 Largest Anaphylaxis Autoinjectors Players Market Share by Revenue in Anaphylaxis Autoinjectors: 2020 & 2024
 Figure 35. Anaphylaxis Autoinjectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 36. Manufacturing Cost Structure of Anaphylaxis Autoinjectors
 Figure 37. Manufacturing Process Analysis of Anaphylaxis Autoinjectors
 Figure 38. Anaphylaxis Autoinjectors Industrial Chain
 Figure 39. Channels of Distribution (Direct Vs Distribution)
 Figure 40. Distributors Profiles
 Figure 41. Bottom-up and Top-down Approaches for This Report
 Figure 42. Data Triangulation
 Figure 43. Key Executives Interviewed

Description

The global Anaphylaxis Autoinjectors market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. 
The North America Anaphylaxis Autoinjectors market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Anaphylaxis Autoinjectors include Ypsomed Holding, Novartis, BD, Medmix Healthcare, Eli Lilly and Company, Sanofi, Mylan, Amgen, SHL Medical, Recipharm, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Anaphylaxis Autoinjectors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anaphylaxis Autoinjectors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

Market Segmentation
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Anaphylaxis Autoinjectors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Anaphylaxis Autoinjectors manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anaphylaxis Autoinjectors revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Related Reports

Global Anaphylaxis Autoinjectors Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Devices & Consumables

Published: 2025-02-14

Pages: 79 Pages

Report ld: 3892213

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

CHOOSE LICENSE TYPE
tip

USD 4250.00

tip

USD 6375.00

tip

USD 8500.00

Add to Cart

Add to Cart

Buy Now

Buy Now

Have a question?
SIMON LEE

English

English

SIMON LEE

+1-62 6295 2442

Online

JOHN WANG

English

English

JOHN WANG

+41 765 899 438

Offline

HITESH

English

English

HITESH

+91-86 6998 6909

Offline

TANG XIN

Japanese

Japanese

TANG XIN

+81-90 3800 9273

Offline

SUNG-BIN YOON

Korean

Korean

SUNG-BIN YOON

+82-2883 1278

Offline

YUJIE TIAN

English

English

YUJIE TIAN

+86-135-2215-3954

Offline

DAMON

Chinese

Chinese

DAMON

+86-133 1872 9947

Offline

General Email:
global@qyresearch.com
WHAT QYRESEARCH OFFER?
Competition

Competition

Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.

Industry Analysis

Industry Analysis

Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.

Market Size

Market Size

Capacity, production, sales, revenue, price, cost etc.

Customized Information

Customized Information

We can offer customized survey and information to meet ourclient's need.

INTEREST IN THIS REPORT?

Get A Free Sample >>
WHY QYR?
  • Fastest report delivery service

    Fastest report delivery service

  • More than 19 years of vast experience

    More than 19 years of vast experience

  • Operation for 24 * 7 & 365 days

    Operation for 24 * 7 & 365 days

  • In-depth and comprehensive analysis

    In-depth and comprehensive analysis

  • Professional and timely after-sales service

    Professional and timely after-sales service

  • Owns large database

    Owns large database

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now